Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shin Poong PharmCo Ltd (019170) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3488
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostatic hyperplasia drugs, among others. It also provides antibiotics, antifungal and antiviral agents, antiulcerants, anti-diabetics, and trichogens. Shin Poong offers cardiovascular, anti-diabetic, NSAIDs, anti-biotic, propulsive, anti-ulcer, anti-arthritis, anti-spasmodic, respiratory, anti-cancer, and anti-helminthic APIs, among others. The company also provides chemotherapeutics, contraceptive agents, and other products. It has its operations through its production facilities located in Gyeonggi-do and Chungcheongbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.

Shin Poong PharmCo Ltd (019170) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Licensing Agreements 13
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Equity Offering 15
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd – Key Competitors 16
Shin Poong PharmCo Ltd – Key Employees 17
Shin Poong PharmCo Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shin Poong Pharma Forms Joint Venture With Laboratoire Francais De Fractionnement 11
Almac Discovery Enters Into Licensing Agreement With Shin Poong Pharma For ALM201 13
Shin Poong Enters Into Licensing Agreement With NovaBay For NeutroPhase 14
Shin Pooong Pharm to Raise USD34.5 Million in Private Placement of Shares 15
Shin Poong PharmCo Ltd, Key Competitors 16
Shin Poong PharmCo Ltd, Key Employees 17
Shin Poong PharmCo Ltd, Other Locations 18
Shin Poong PharmCo Ltd, Subsidiaries 18

List of Figures
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shin Poong PharmCo Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shin Poong PharmCo Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Tower Corporation:企業の戦略・SWOT・財務情報
    American Tower Corporation - Strategy, SWOT and Corporate Finance Report Summary American Tower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Covalon Technologies Ltd (COV)-医療機器分野:企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Halo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • Collagen Solutions Plc (COS):企業の財務・戦略的SWOT分析
    Summary Collagen Solutions Plc (Collagen Solutions), formerly Healthcare Investment Opportunities Plc, is a medical device company that develops, manufactures and supplies medical grade collagen biomaterials and components. The company provides sourcing and supply of high grade collagen; provision o …
  • Commercial Bank Of Kuwait Sak
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PPL Corporation:発電所・企業SWOT分析
    PPL Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Gordon Food Service Inc:企業の戦略的SWOT分析
    Gordon Food Service Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Telia Company AB:企業の戦略・SWOT・財務情報
    Telia Company AB - Strategy, SWOT and Corporate Finance Report Summary Telia Company AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Enzon Pharmaceuticals Inc (ENZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Enzon Pharmaceuticals Inc (Enzon), formerly Enzon, Inc., is a pharmaceutical company that receives royalty revenues from existing licensing arrangements. The company has licensing arrangements with other companies related to sales of their four marketed drug products, namely, PegIntron, Syla …
  • Applus Services, S.A.:企業のM&A・事業提携・投資動向
    Applus Services, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Applus Services, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Public Financial Holdings Limited (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Limited (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Wilbur-Ellis Company:企業の戦略・SWOT・財務情報
    Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report Summary Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Seven West Media Limited:企業のM&A・事業提携・投資動向
    Seven West Media Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seven West Media Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報
    Summary Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is …
  • Melkior Resources Inc. (MKR):企業の財務・戦略的SWOT分析
    Melkior Resources Inc. (MKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sirtex Medical Ltd (SRX):医療機器:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Krka, d. d., Novo mesto:企業の戦略・SWOT・財務情報
    Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report Summary Krka, d. d., Novo mesto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Barco N.V.:企業の戦略・SWOT・財務情報
    Barco N.V. - Strategy, SWOT and Corporate Finance Report Summary Barco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆